• Events
  • Media center
  • Careers
  • Contact
  • Support us
EORTC
  • Activities
    • Clinical trials
    • Other research initiatives
    • Data sharing
    • Quality assurance
    • Education & training
    • Early career
    • Public policy
  • Research fields
    • Tumours
    • Cross-discipline
  • Network & partners
    • Members
    • Partners & supporters
    • Government bodies
    • Liaison offices
  • Research tools
    • Study tools
    • Clinical trials database
    • Bibliography
    • Guidelines
    • Request for data
  • About us
    • Our mission
    • Strategic overview
    • Policies
    • Operating principles
    • Funding
    • History
    • Governance
    • Headquarters
    • Progress and Activity Report 2016

Year: 2015

Melanoma Group / News

Will adjuvant pembrolizumab improve recurrence-free survival for patients with high-risk Stage III melanoma?

14 Sep
News

EORTC Presentations at ECC2015 in Vienna

24 Aug
News

Running Team to raise support for EORTC cancer research at Belfius Brussels Marathon

21 Aug
Breast Cancer Group / News / SPECTA / SPECTAcolor

Dennis & Mireille Gillings Foundation Donates €1m to EORTC Cancer Research Fund

7 Aug
Breast Cancer Group / News

Irradiation of regional nodes in four thousand stage I – III breast cancer patients affects overall survival

3 Aug
Lymphoma Group / News

PET adapted treatment improves outcome of patients with stages I/II Hodgkin Lymphoma

13 Jul
News / SPECTA / SPECTAlung / Videos

SPECTAlung: improving clinical trial access for patients with thoracic tumors

10 Jul
News / Quality of Life Group / Soft Tissue and Bone Sarcoma Group

Pazopanib improves progression-free survival without impairing health-related quality of life

6 Jul
News

Translating Basic Research to the Patient’s Bedside

2 Jul
Gastrointestinal Tract Cancer Group / News

EORTC presentations at ESMO World Congress on Gastrointestinal Cancer

30 Jun
« 1 2 3 4 5 … 31 »
  • Activities
    • Clinical trials
    • Other research initiatives
    • Data sharing
    • Quality assurance
    • Education & training
    • Early career
    • Public policy
  • Research fields
    • Tumours
    • Cross-discipline
  • Network & partners
    • Members
    • Partners & supporters
    • Government bodies
    • Liaison offices
  • Research tools
    • Study tools
    • Clinical trials database
    • Bibliography
    • Guidelines
    • Request for data
  • About us
    • Our mission
    • Strategic overview
    • Policies
    • Operating principles
    • Funding
    • History
    • Governance
    • Headquarters
    • Progress and Activity Report 2016
Subscribe to our newsletter Member area Eur. J. Cancer
Follow us on
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • © EORTC
  • Legal notice
  • HONcode
  • Intranet